S. M. Lippman - Concepedia

Author

S. M. Lippman

The University of Texas MD Anderson Cancer Center

Also Known As

S Lippman, S M Lippman, S. Lippman, S. M. Lippman, S.M. Lippman, Scott M. Lippman

Publications

4.2K

Citations

H-Index

Concepts

All Affiliations

The University of Texas MD Anderson Cancer Center Thoracic Surgery Foundation Roche (Switzerland)Hospital Civil de Guadalajara

About

S. M. Lippman is an author at The University of Texas MD Anderson Cancer Center specializing in medicine, oncology, and cancer research.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	12	12	684
2	Cell Biology	5	5	406
3	Gastroenterology	1	1	21
4	General Surgery	1	1	84
5	Head And Neck Surgery	1	1	61

S. M. Lippman

Publications

3.8K

Citations

H-Index

Page 1

	Year	Citations
Prevention of Second Primary Tumors with Isotretinoin in Squamous-Cell Carcinoma of the Head and Neck Waun Ki Hong, S. M. Lippman, Loretta M. Itri, New England Journal of Medicine	1990	1.4K
Suppression of Retinoic Acid Receptor–β in Premalignant Oral Lesions and Its Up-Regulation by Isotretinoin Reuben Lotan, Xiaochun Xu, S. M. Lippman, New England Journal of Medicine	1995	414
13-cis-Retinoic Acid and Interferon -2a: Effective Combination. Therapy for Advanced Squamous Cell Carcinoma of the Skin S. M. Lippman, David Parkinson, Loretta M. Itri, JNCI Journal of the National Cancer Institute	1992	395
13-cis-Retinoic Acid Plus Interferon -2a: Highly Active Systemic Theraphy for Squamous Cell Carcinoma of the Cervix S. M. Lippman, J. J. Kavanagh, M. Paredes-Espinoza, JNCI Journal of the National Cancer Institute	1992	323
Phenotype and Genotype of Advanced Premalignant Head and Neck Lesions After Chemopreventive Therapy Li Mao, V. Papadimitrakopoulou, Dong M. Shin, JNCI Journal of the National Cancer Institute	1998	167
Progressive decrease in nuclear retinoic acid receptor beta messenger RNA level during breast carcinogenesis. Xiaochun Xu, Nour Sneige, Xiaoming Liu, PubMed Breast OncologyEstrogen ReceptorPathologyCancer BiologyCell Regulation	1997	148
Maximum-tolerated dose defined for single-agent gemcitabine: a phase I dose-escalation study in chemotherapy-naive patients with advanced non-small-cell lung cancer. Frank V. Fossella, S. M. Lippman, Dong M. Shin, Journal of Clinical Oncology	1997	129
The Role of Neck Dissection After Chemoradiotherapy for Oropharyngeal Cancer With Advanced Nodal Disease Gary L. Clayman, Chad Jeffery Johnson, William B. Morrison, Archives of Otolaryngology - Head and Neck Surgery	2001	114
13-cis-Retinoic Acid Plus Interferon- 2a in Locally Advanced Squamous Cell Carcinoma of the Cervix S. M. Lippman, J. J. Kavanagh, M. Paredes-Espinoza, JNCI Journal of the National Cancer Institute Tumor BiologyOncologyCervical CancerSwitzerland SearchMalignant Disease	1993	90
Retinoic acid and interferon in human cancer: mechanistic and clinical studies. D M Moore, D V Kalvakolanu, S. M. Lippman, PubMed	1994	87

Page 1